York Charles N II
Insider CIK 1655962 · AGLE Chief Financial Officer and VP · DAWN COO, CFO and Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 151,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 46,375 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 72,875 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 118,125 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 497,667 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 116,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 162,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 162,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 188,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 6,750 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer | 2026-04-23 | 2026-04-23 | 312,025 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2026-02-17 | 2026-02-18 | 6,065 | $11.60 | $70.4K | 312,025 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 6,625 | — | $0 | 46,375 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 2,250 | — | $0 | 6,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 7,875 | — | $0 | 118,125 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 6,625 | — | $0 | 72,875 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 7,875 | — | $0 | 318,090 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 6,625 | — | $0 | 310,215 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 6,625 | — | $0 | 303,590 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 2,250 | — | $0 | 296,965 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 126,000 | — | $0 | 126,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 188,000 | — | $0 | 188,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-11-17 | 2025-11-18 | 4,062 | $8.91 | $36.2K | 294,715 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 2,250 | — | $0 | 9,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 6,625 | — | $0 | 53,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 6,625 | — | $0 | 79,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 1,375 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 6,625 | — | $0 | 298,777 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 2,250 | — | $0 | 285,527 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 1,375 | — | $0 | 283,277 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 6,625 | — | $0 | 292,152 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 162,000 | — | $0 | 162,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 497,667 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 116,000 | — | $0 | 116,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 162,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 162,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 162,000 | — | $0 | 162,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 116,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 151,000 | — | $0 | 151,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 151,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 497,667 | — | $0 | 497,667 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-08-18 | 2025-08-19 | 4,106 | $6.77 | $27.8K | 278,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 1,375 | — | $0 | 1,375 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 2,250 | — | $0 | 11,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 6,625 | — | $0 | 59,625 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 6,625 | — | $0 | 86,125 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 6,625 | — | $0 | 282,106 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 6,625 | — | $0 | 275,481 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 2,250 | — | $0 | 268,856 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 1,375 | — | $0 | 266,606 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-05-16 | 2025-05-19 | 4,282 | $6.26 | $26.8K | 265,231 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 1,375 | — | $0 | 2,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 2,250 | — | $0 | 13,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 6,625 | — | $0 | 66,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 6,625 | — | $0 | 92,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 6,625 | — | $0 | 262,888 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 6,625 | — | $0 | 269,513 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 2,250 | — | $0 | 256,263 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 1,375 | — | $0 | 254,013 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-02-18 | 2025-02-21 | 4,370 | $11.96 | $52.3K | 252,638 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 2,250 | — | $0 | 15,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 1,375 | — | $0 | 4,125 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 6,625 | — | $0 | 72,875 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 6,625 | — | $0 | 99,375 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 6,625 | — | $0 | 250,383 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 1,375 | — | $0 | 241,508 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 2,250 | — | $0 | 243,758 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 6,625 | — | $0 | 257,008 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-01-15 | 2025-01-31 | 162,000 | — | $0 | 162,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-01-15 | 2025-01-31 | 106,000 | — | $0 | 106,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-11-18 | 2024-11-19 | 2,602 | $13.21 | $34.4K | 240,133 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-11-15 | 2024-11-19 | 2,250 | — | $0 | 18,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-11-15 | 2024-11-19 | 1,375 | — | $0 | 5,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-11-15 | 2024-11-19 | 6,625 | — | $0 | 79,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-11-15 | 2024-11-19 | 1,375 | — | $0 | 233,860 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-11-15 | 2024-11-19 | 6,625 | — | $0 | 242,735 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-11-15 | 2024-11-19 | 2,250 | — | $0 | 236,110 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-08-16 | 2024-08-19 | 2,633 | $14.00 | $36.9K | 232,485 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-08-15 | 2024-08-19 | 6,625 | — | $0 | 86,125 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-08-15 | 2024-08-19 | 2,250 | — | $0 | 20,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-08-15 | 2024-08-19 | 1,375 | — | $0 | 6,875 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-08-15 | 2024-08-19 | 1,375 | — | $0 | 226,243 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-08-15 | 2024-08-19 | 2,250 | — | $0 | 228,493 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-08-15 | 2024-08-19 | 6,625 | — | $0 | 235,118 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-05-16 | 2024-05-17 | 2,675 | $16.08 | $43.0K | 224,868 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-05-15 | 2024-05-17 | 1,375 | — | $0 | 8,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-05-15 | 2024-05-17 | 2,250 | — | $0 | 22,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-05-15 | 2024-05-17 | 6,625 | — | $0 | 92,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-05-15 | 2024-05-17 | 2,250 | — | $0 | 220,918 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-05-15 | 2024-05-17 | 6,625 | — | $0 | 227,543 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-05-15 | 2024-05-17 | 1,375 | — | $0 | 218,668 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-05-03 | 2024-05-03 | 8,078 | $17.85 | $144.2K | 217,293 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-05-02 | 2024-05-03 | 200 | $17.90 | $3.6K | 225,371 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-05-01 | 2024-05-03 | 52,183 | $17.89 | $933.6K | 225,571 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-02-16 | 2024-02-20 | 2,666 | $15.25 | $40.7K | 277,754 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-02-15 | 2024-02-20 | 6,625 | — | $0 | 99,375 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-02-15 | 2024-02-20 | 2,250 | — | $0 | 24,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-02-15 | 2024-02-20 | 1,375 | — | $0 | 9,625 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-02-15 | 2024-02-20 | 1,375 | — | $0 | 271,545 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-02-15 | 2024-02-20 | 2,250 | — | $0 | 273,795 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-02-15 | 2024-02-20 | 6,625 | — | $0 | 280,420 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-01-05 | 2024-01-09 | 162,000 | — | $0 | 162,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-01-05 | 2024-01-09 | 106,000 | — | $0 | 106,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2023-11-16 | 2023-11-17 | 956 | $11.69 | $11.2K | 270,170 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-11-15 | 2023-11-17 | 1,375 | — | $0 | 11,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-11-15 | 2023-11-17 | 2,250 | — | $0 | 27,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-11-15 | 2023-11-17 | 2,250 | — | $0 | 271,126 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-11-15 | 2023-11-17 | 1,375 | — | $0 | 268,876 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2023-08-17 | 2023-08-17 | 922 | $13.86 | $12.8K | 267,501 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-08-15 | 2023-08-17 | 1,375 | — | $0 | 12,375 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-08-15 | 2023-08-17 | 2,250 | — | $0 | 29,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-08-15 | 2023-08-17 | 2,250 | — | $0 | 268,423 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-08-15 | 2023-08-17 | 1,375 | — | $0 | 266,173 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2023-05-16 | 2023-05-17 | 955 | $13.12 | $12.5K | 264,798 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-05-15 | 2023-05-17 | 1,375 | — | $0 | 13,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-05-15 | 2023-05-17 | 2,250 | — | $0 | 31,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-05-15 | 2023-05-17 | 2,250 | — | $0 | 265,753 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-05-15 | 2023-05-17 | 1,375 | — | $0 | 263,503 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2023-02-17 | 2023-02-21 | 9,377 | $20.03 | $187.8K | 262,128 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2023-02-16 | 2023-02-17 | 930 | $19.57 | $18.2K | 271,505 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-02-15 | 2023-02-17 | 2,250 | — | $0 | 33,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-02-15 | 2023-02-17 | 1,375 | — | $0 | 15,125 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-02-15 | 2023-02-17 | 2,250 | — | $0 | 272,435 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-02-15 | 2023-02-17 | 1,375 | — | $0 | 270,185 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2023-01-20 | 2023-01-23 | 10,000 | $22.75 | $227.5K | 268,810 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2023-01-17 | 2023-01-19 | 116,000 | — | $0 | 116,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2023-01-17 | 2023-01-19 | 36,000 | — | $0 | 36,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-12-20 | 2022-12-22 | 10,000 | $20.07 | $200.7K | 276,497 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-11-21 | 2022-11-22 | 300 | $21.39 | $6.4K | 286,497 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-11-21 | 2022-11-22 | 9,700 | $20.74 | $201.2K | 286,797 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-11-16 | 2022-11-17 | 430 | $21.46 | $9.2K | 296,497 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2022-11-15 | 2022-11-17 | 1,375 | — | $0 | 16,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2022-11-15 | 2022-11-17 | 1,375 | — | $0 | 295,776 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-11-01 | 2022-11-03 | 10,000 | $20.03 | $200.3K | 294,401 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-10-03 | 2022-10-05 | 10,000 | $20.05 | $200.5K | 304,401 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-09-01 | 2022-09-06 | 1,394 | $23.80 | $33.2K | 314,401 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-09-01 | 2022-09-06 | 8,606 | $23.16 | $199.3K | 315,795 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-08-16 | 2022-08-17 | 1,089 | $24.31 | $26.5K | 324,401 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2022-08-15 | 2022-08-17 | 4,125 | — | $0 | 17,875 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2022-08-15 | 2022-08-17 | 4,125 | — | $0 | 325,490 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-08-04 | 2022-08-05 | 10,000 | $20.05 | $200.5K | 321,365 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-07-18 | 2022-07-20 | 2,500 | $20.00 | $50.0K | 331,365 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-07-08 | 2022-07-12 | 1,416 | $20.00 | $28.3K | 333,865 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-07-05 | 2022-07-06 | 800 | $20.00 | $16.0K | 335,281 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2022-07-01 | 2022-07-06 | 1,479 | $20.00 | $29.6K | 336,081 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2022-01-18 | 2022-01-20 | 151,000 | — | $0 | 151,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2022-01-18 | 2022-01-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2020-02-14 | 2020-02-19 | 126,000 | — | $0 | 126,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2019-02-28 | 2019-03-01 | 87,600 | — | $0 | 87,600 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2018-02-20 | 2018-02-22 | 92,100 | — | $0 | 92,100 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-05 | 2017-12-05 | 10,241 | $4.76 | $48.7K | 34,787 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-04 | 2017-12-05 | 3,259 | $4.97 | $16.2K | 24,546 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-12-01 | 2017-12-05 | 6,500 | $4.59 | $29.8K | 21,287 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-08-22 | 2017-08-24 | 58,500 | — | $0 | 58,500 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-08-15 | 2017-12-05 | 1,959 | $2.52 | $4.9K | 14,787 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2017-03-20 | 2017-03-22 | 90,000 | — | $0 | 90,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-02-15 | 2017-12-05 | 2,000 | $4.28 | $8.6K | 12,828 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2016-08-15 | 2017-12-05 | 2,000 | $3.99 | $8.0K | 10,828 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2016-05-17 | 2016-05-19 | 55,000 | — | $0 | 55,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion deriv | 2016-04-12 | 2016-04-12 | 1,324 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion deriv | 2016-04-12 | 2016-04-12 | 9,523 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion deriv | 2016-04-12 | 2016-04-12 | 2,037 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion | 2016-04-12 | 2016-04-12 | 1,324 | — | $0 | 8,828 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion | 2016-04-12 | 2016-04-12 | 11,560 | — | $0 | 11,560 | SEC↗ |